\-\ Texto\\:\\ \ \(0\)\
\-\ area\\ of\\ thickening\\ and\\ nodularity\\ in\\ right\\ breast\\ in\\ the\\ upper\\-outer\\ aspect\\.\\ this\\ area\\ is\\ ill\\-defined\\ but\\ not\\ hardened\\.\\ there\\ were\\ no\\ skin\\ changes\\ or\\ redness\\.\ \(0\)\
\-\ ultrasound\\-guided\\ core\\ biopsies\\ were\\ performed\\ for\\ pathologic\\ diagnosis\\ of\\ this\\ lesion\\.\\ final\\ diagnosis\\ on\\ pathology\\:\\ invasive\\ mammary\\ carcinoma\\ with\\ ductal\\ and\\ lobular\\ features\\,\\ nottingham\\ grade\\ ii\\,\\ nottingham\\ score\\ 6\\ \\(tubules\\=3\\,\\ nuclei\\=2\\,\\ mitoses\\=1\\)\\,\\ involving\\ 4\\/4\\ needle\\ core\\ biopsies\\,\\ with\\ greatest\\ tumor\\ size\\ 1\\.1cm\\,\\ no\\ definite\\ venous\\ or\\ lymphatic\\ invasion\\,\\ and\\ no\\ microcalcifications\\ identified\\.\\ er\\+\\/pr\\+\\;\\ her2\\/neu\\ \\-\\.\ \(0\)\
\-\ screening\\ mammogram\\ \\(cc\\ and\\ mlo\\ views\\)\\ of\\ both\\ breasts\\ were\\ performed\\.\\ mmg\\ demonstrated\\ no\\ mass\\ or\\ suspicious\\ microcalcifications\\.\\ however\\,\\ there\\ was\\ a\\ generalized\\,\\ ill\\-defined\\,\\ increased\\ density\\ measuring\\ 2\\.5\\ cm\\ in\\ the\\ 12\\ o\\â\\€\\™clock\\ position\\ of\\ the\\ mid\\ right\\ breast\\ compared\\ to\\ previous\\ mmgs\\,\\ markedly\\ asymmetrical\\ compared\\ to\\ the\\ unremarkable\\ left\\ side\\.\\ there\\ was\\ also\\ mild\\ tissue\\ retraction\\ throughout\\ the\\ dense\\ area\\.\ \(0\)\
\-\ these\\ findings\\ in\\ the\\ r\\ breast\\ on\\ mmg\\ and\\ us\\ when\\ correlated\\ with\\ physical\\ exam\\ were\\ graded\\ bi\\-rads\\ category\\ 4\\ with\\ prompt\\ clinical\\ attention\\ advised\\.\ \(0\)\
\-\ follow\\-up\\ ultrasound\\ examination\\ \\ in\\ the\\ transverse\\ and\\ longitudinal\\ planes\\ of\\ the\\ right\\ breast\\ at\\ 12\\ o\\â\\€\\™clock\\,\\ zone\\ 2\\-c\\,\\ revealed\\ a\\ 1\\.4\\ x\\ 1\\.5\\ cm\\ area\\ of\\ hypoechogenicity\\ suspicious\\ for\\ malignancy\\.\ \(0\)\
\-\ invasive\\ lobular\\ carcinoma\ \(2\)\
\-\ \\>\\>\\ lcis\ \(0\)\
\-\ \\>\\>\\ invasive\\ lobular\\ carcinoma\ \(0\)\
\-\ \\>\\>\\ inflammatory\\ breast\\ cancer\ \(0\)\
\-\ \\<p\\>pt\\ presented\\ to\\ pcp\\ with\\ an\\ area\\ of\\ thickening\\ in\\ the\\ skin\\ and\\ subcutaneous\\ tissues\\ of\\ the\\ upper\\-outer\\ aspect\\ of\\ the\\ r\\ breast\\ at\\ the\\ 10\\ o\\â\\€\\™clock\\ position\\,\\ circular\\ in\\ shape\\ and\\ measuring\\ approximately\\ 5\\ x\\ 5\\ cm\\ which\\ was\\ noticed\\ for\\ several\\ wks\\.\\ no\\ c\\/o\\ pain\\,\\ redness\\,\\ discharge\\,\\ nausea\\,\\ vomiting\\,\\ diarrhea\\,\\ constipation\\,\\ or\\ recent\\ weight\\ change\\.\\ pt\\ has\\ previously\\ had\\ regular\\ annual\\ mammograms\\,\\ the\\ last\\ being\\ one\\ year\\ prior\\ to\\ presentation\\.\\<\\/p\\>\ \(0\)\
\-\ \\<p\\>her\\ relevant\\ history\\ is\\ as\\ follows\\:\ \(0\)\
\-\ age\\ of\\ menarche\\ unknown\\;\\ lmp\\ 33\\ years\\ ago\\;\ \(0\)\
\-\ no\\ fhx\\ or\\ first\\ degree\\ relative\\ with\\ breast\\ or\\ ovarian\\ cancer\\;\ \(0\)\
\-\ no\\ prior\\ personal\\ h\\/o\\ breast\\ disease\\;\ \(0\)\
\-\ taking\\ premarin\\ for\\ \\"many\\"\\ years\\ following\\ tah\\/bso\\;\ \(0\)\
\-\ age\\ at\\ first\\ pregnancy\\ \\=\\ 29\\,\\ did\\ not\\ breast\\ feed\\;\ \(0\)\
\-\ no\\ montly\\ breast\\ self\\ exams\\ performed\\;\ \(0\)\
\-\ active\\ 1ppd\\ smoker\\;\ \(0\)\
\-\ does\\ not\\ exercise\\<\\/p\\>\ \(0\)\
\-\ invasive\\ lobular\\ carcinoma\\ \\(ilc\\)\\ of\\ the\\ breast\\ is\\ the\\ second\\ most\\ common\\ type\\ of\\ primary\\ breast\\ cancer\\,\\ accounting\\ for\\ 10\\-15\\%\\ of\\ cases\\.\\ 6\\-28\\%\\ of\\ cases\\ are\\ bilateral\\,\\ approximately\\ twice\\ the\\ risk\\ of\\ invasive\\ ductal\\ carcinoma\\.\\ \ \(0\)\
\-\ risk\\ factors\\ for\\ breast\\ cancer\\ include\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ age\\ \\>\\ 50\\ \ \(0\)\
\-\ \\â\\€\\¢\\ genetics\\ \\(brca1\\,\\ brca2\\,\\ her2\\,\\ p53\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ personal\\ history\\ of\\ breast\\ cancer\\ \ \(0\)\
\-\ \\â\\€\\¢\\ family\\ history\\,\\ especially\\ in\\ first\\-degree\\ relative\\ \ \(0\)\
\-\ \\â\\€\\¢\\ previous\\ breast\\ biopsy\\ showing\\ benign\\ conditions\\ \\(e\\.g\\.\\ lcis\\ or\\ atypical\\ hyperplasia\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ menarche\\ before\\ age\\ 12\\ or\\ menopause\\ after\\ age\\ 55\\ \ \(0\)\
\-\ \\â\\€\\¢\\ delayed\\ childbirth\\ after\\ age\\ 30\\ \ \(0\)\
\-\ \\â\\€\\¢\\ alcohol\\ \ \(0\)\
\-\ \\â\\€\\¢\\ high\\-fat\\ diet\\ \ \(0\)\
\-\ \\â\\€\\¢\\ obesity\\ \\(weight\\ gained\\ as\\ adult\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ previous\\ radiation\\ therapy\\,\\ e\\.g\\.\\ tx\\ hodgkins\\â\\€\\™\\ disease\\ \ \(0\)\
\-\ \\â\\€\\¢\\ combined\\ estrogen\\ and\\ progesterone\\ replacement\\ therapy\\ \\(chrt\\)\\ \ \(0\)\
\-\ ilc\\ has\\ been\\ historically\\ difficult\\ to\\ diagnose\\ early\\ due\\ to\\ lack\\ of\\ pathomnemonic\\ radiographic\\ signs\\.\\ classically\\,\\ ilc\\ exhibits\\ the\\ \\â\\€\\˜indian\\ file\\â\\€\\™\\ appearance\\ of\\ small\\,\\ regular\\ non\\-cohesive\\ cells\\ arranged\\ in\\ single\\ files\\.\\ the\\ subtle\\ mammographic\\ findings\\ are\\ often\\ due\\ to\\ malignant\\ cells\\ permeating\\ the\\ parenchyma\\ around\\ normal\\ ducts\\,\\ inducing\\ little\\ connective\\ tissue\\ reaction\\.\\ \ \(0\)\
\-\ physical\\ exam\\ may\\ also\\ be\\ non\\-specific\\ in\\ ilc\\ and\\ may\\ include\\ vague\\ areas\\ of\\ thickening\\ which\\ may\\ be\\ confused\\ with\\ benign\\ breast\\ change\\,\\ especially\\ in\\ the\\ younger\\ patient\\.\\ \ \(0\)\
\-\ us\\ and\\ mr\\ imaging\\ has\\ been\\ shown\\ to\\ be\\ more\\ sensitive\\ than\\ mammography\\ for\\ invasive\\ cancer\\,\\ but\\ with\\ the\\ risk\\ of\\ overestimating\\ the\\ extent\\ of\\ the\\ tumor\\.\\ combined\\ mammography\\,\\ clinical\\ exam\\,\\ and\\ mri\\ were\\ more\\ sensitive\\ at\\ detecting\\ ilc\\ than\\ any\\ other\\ individual\\ test\\ or\\ combination\\ of\\ tests\\.\\ \ \(0\)\
\-\ the\\ majority\\ of\\ ilcs\\ are\\ of\\ intermediate\\ histological\\ grade\\ \\(grade\\ 2\\)\\ and\\ er\\+\\;\\ prognosis\\ is\\ similar\\ to\\ that\\ of\\ invasive\\ ductal\\ carcinomas\\ of\\ similar\\ grade\\.\\ \ \(0\)\
\-\ imaging\\ features\\ of\\ primary\\ invasive\\ lobular\\ carcinoma\\ \ \(0\)\
\-\ mammogram\\:\\ \ \(1\)\
\-\ \\â\\€\\¢\\ micro\\-calcification\\ less\\ frequently\\ observed\\ \\(6\\.5\\-25\\%\\)\\ unlike\\ in\\ ductal\\ ca\\ \ \(1\)\
\-\ \\â\\€\\¢\\ speculated\\ mass\\ \ \(1\)\
\-\ \\â\\€\\¢\\ asymmetric\\ density\\ without\\ definable\\ margins\\ \ \(1\)\
\-\ \\â\\€\\¢\\ architectural\\ distortion\\ without\\ an\\ obvious\\ mass\\ \ \(1\)\
\-\ \\â\\€\\¢\\ better\\ demonstrated\\ on\\ craniocaudal\\ view\\ \ \(1\)\
\-\ because\\ these\\ subtle\\ findings\\ are\\ often\\ confused\\ with\\ normal\\ glandular\\ tissue\\,\\ the\\ relative\\ infrequency\\ of\\ micro\\-calicification\\,\\ and\\ the\\ insidious\\ growth\\ of\\ the\\ tumor\\,\\ ilc\\ is\\ often\\ undetected\\ until\\ clinically\\ palpable\\.\\ at\\ this\\ stage\\,\\ skin\\ tethering\\,\\ skin\\ thickening\\,\\ and\\ nipple\\ retraction\\ are\\ often\\ apparent\\.\\ \ \(0\)\
\-\ ultrasound\\:\\ \ \(11\)\
\-\ \\â\\€\\¢\\ useful\\ adjunct\\ to\\ mammography\\ \ \(1\)\
\-\ \\â\\€\\¢\\ ill\\-definied\\ hypoechoic\\ mass\\ with\\ acoustic\\ attenuation\\ \ \(1\)\
\-\ \\â\\€\\¢\\ fna\\ often\\ do\\ not\\ yield\\ much\\ information\\ due\\ to\\ the\\ relative\\ sparseness\\ of\\ malignancy\\ cells\\ within\\ these\\ tumors\\ \ \(0\)\
\-\ \\â\\€\\¢\\ wide\\-bore\\ needle\\ biopsy\\ should\\ be\\ performed\\ if\\ fnas\\ inconclusive\\ \ \(0\)\
\-\ contrast\\-enhanced\\ mri\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ highly\\ sensitive\\ in\\ detecting\\ ilc\\ and\\ the\\ extent\\ of\\ ilc\\ \ \(0\)\
\-\ \\â\\€\\¢\\ may\\ be\\ of\\ value\\ in\\ preoperative\\ planning\\ as\\ well\\ as\\ the\\ diagnosis\\ of\\ multifocal\\ or\\ contralateral\\ involvement\\ \ \(1\)\
\-\ american\\ college\\ of\\ radiology\\ \\(acr\\)\\ \\/\\ breast\\ imaging\\ reporting\\ and\\ data\\ system\\ \\(bi\\-rads\\)\\ \ \(0\)\
\-\ bi\\-rads\\ assessment\\ categories\\:\\ \ \(0\)\
\-\ category\\ 0\\:\\ need\\ additional\\ imaging\\ evaluation\\ \ \(0\)\
\-\ category\\ 1\\:\\ negative\\ \ \(0\)\
\-\ category\\ 2\\:\\ benign\\ finding\\ \ \(0\)\
\-\ category\\ 3\\:\\ probably\\ benign\\ finding\\ \\-\\ short\\ interval\\ follow\\-up\\ suggested\\ \ \(0\)\
\-\ category\\ 4\\:\\ suspicious\\ abnormality\\ \\-\\ biopsy\\ should\\ be\\ considered\\ \ \(0\)\
\-\ category\\ 5\\:\\ highly\\ suggestive\\ of\\ malignancy\\ \\-\\ appropriate\\ action\\ should\\ be\\ taken\\ \ \(0\)\
\-\ metastatic\\ manifestations\\ of\\ invasive\\ lobular\\ breast\\ carcinoma\\ \ \(0\)\
\-\ gastrointestinal\\,\\ gynecological\\,\\ peritoneal\\,\\ retroperitoneal\\,\\ bone\\ marrow\\,\\ and\\ leoptomeningeal\\ metastases\\ are\\ more\\ frequently\\ seen\\ with\\ ilc\\ than\\ with\\ idc\\.\\ ct\\,\\ mri\\,\\ and\\ pet\\ scans\\ are\\ useful\\,\\ but\\ somewhat\\ limited\\ in\\ revealing\\ the\\ full\\ extent\\ of\\ metastatic\\ ilc\\.\\ knowledge\\ of\\ pattern\\ of\\ metastasis\\ is\\ useful\\ for\\ interpretation\\ of\\ these\\ imaging\\ studies\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ bone\\ \\(most\\ frequent\\ metastasis\\ site\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ gastrointestinal\\ \\â\\€\\“\\ \ \(0\)\
\-\ \\ \\ o\\ esophagus\\,\\ stomach\\ \\(produces\\ linitis\\ plastica\\)\\,\\ small\\ bowel\\ \\(50\\%\\ of\\ mets\\)\\ and\\ large\\ bowel\\ wall\\ thickening\\ \ \(0\)\
\-\ \\ \\ o\\ can\\ present\\ as\\ obstruction\\,\\ hemorrhage\\,\\ or\\ performation\\ \ \(0\)\
\-\ \\â\\€\\¢\\ gynecologic\\ \\â\\€\\“\\ \ \(0\)\
\-\ \\ \\ o\\ uterus\\ \\â\\€\\“\\ ilc\\ is\\ most\\ common\\ extragenital\\ neoplasm\\ to\\ metastasize\\ to\\ uterus\\ \ \(0\)\
\-\ \\ \\ o\\ ovary\\,\\ vagina\\,\\ parametrium\\ \ \(0\)\
\-\ \\â\\€\\¢\\ genitourinary\\ system\\ \\â\\€\\“\\ direct\\ invation\\ of\\ kidneys\\ and\\ ureters\\ \ \(0\)\
\-\ \\â\\€\\¢\\ peritoneum\\ \\â\\€\\“\\ manifests\\ as\\ small\\ nodules\\ which\\ may\\ become\\ confluent\\ \ \(0\)\
\-\ \\â\\€\\¢\\ retroperitoneum\\ \\â\\€\\“\\ ureteric\\ obstruction\\ and\\ hydronephrosis\\ \ \(0\)\
\-\ \\â\\€\\¢\\ leptomeninges\\ \ \(0\)\
\-\ \\â\\€\\¢\\ orbital\\ metastases\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ilc\\:\\ 0\\.419784217240471\ \(0\)\
\-\ breast\\:\\ 0\\.311915699560337\ \(0\)\
\-\ of\\:\\ 0\\.19613546364104106\ \(0\)\
\-\ invasive\\:\\ 0\\.19542789380813091\ \(0\)\
\-\ category\\:\\ 0\\.19202581105409924\ \(0\)\
\-\ the\\:\\ 0\\.14760779732293763\ \(0\)\
\-\ lobular\\:\\ 0\\.14533561904206127\ \(0\)\
\-\ and\\:\\ 0\\.10848212730390999\ \(0\)\
\-\ carcinoma\\:\\ 0\\.09991655833259036\ \(0\)\
\-\ cancer\\:\\ 0\\.09536684557848872\ \(0\)\
\-\ or\\:\\ 0\\.0913168071378743\ \(0\)\
\-\ age\\:\\ 0\\.08988872972634028\ \(0\)\
\-\ in\\:\\ 0\\.08904526155872171\ \(0\)\
\-\ clock\\:\\ 0\\.08558941844086522\ \(0\)\
\-\ relative\\:\\ 0\\.08456102998320962\ \(0\)\
\-\ ductal\\:\\ 0\\.08399851702524178\ \(0\)\
\-\ thickening\\:\\ 0\\.08117210655085824\ \(0\)\
\-\ often\\:\\ 0\\.07785317193022212\ \(0\)\
\-\ to\\:\\ 0\\.07755428203310531\ \(0\)\
\-\ area\\:\\ 0\\.07729412357257248\ \(0\)\
\-\ nottingham\\:\\ 0\\.07632440313463108\ \(0\)\
\-\ mmg\\:\\ 0\\.07632440313463108\ \(0\)\
\-\ mammography\\:\\ 0\\.07460238337056789\ \(0\)\
\-\ lcis\\:\\ 0\\.07293204186004419\ \(0\)\
\-\ her2\\:\\ 0\\.07293204186004419\ \(0\)\
\-\ skin\\:\\ 0\\.07100748339885067\ \(0\)\
\-\ sensitive\\:\\ 0\\.07041710085650794\ \(0\)\
\-\ menarche\\:\\ 0\\.06865817210040961\ \(0\)\
\-\ grade\\:\\ 0\\.06863841963307021\ \(0\)\
\-\ useful\\:\\ 0\\.06834944104572721\ \(0\)\
\-\ be\\:\\ 0\\.06776197930759167\ \(0\)\
\-\ benign\\:\\ 0\\.06556920112000149\ \(0\)\
\-\ extent\\:\\ 0\\.06551728262936636\ \(0\)\
\-\ suspicious\\:\\ 0\\.06396888966615602\ \(0\)\
\-\ are\\:\\ 0\\.06338457808285936\ \(0\)\
\-\ imaging\\:\\ 0\\.06270418471610044\ \(0\)\
\-\ no\\:\\ 0\\.06207992173921579\ \(0\)\
\-\ were\\:\\ 0\\.061503547007179235\ \(0\)\
\-\ personal\\:\\ 0\\.06066379734727809\ \(0\)\
\-\ may\\:\\ 0\\.06004317972031907\ \(0\)\
\-\ for\\:\\ 0\\.05786164276590121\ \(0\)\
\-\ as\\:\\ 0\\.057519788911256496\ \(0\)\
\-\ performed\\:\\ 0\\.05646981787647846\ \(0\)\
\-\ with\\:\\ 0\\.05607218700966574\ \(0\)\
\-\ microcalcifications\\:\\ 0\\.05589028109501435\ \(0\)\
\-\ redness\\:\\ 0\\.055192661162938396\ \(0\)\
\-\ detecting\\:\\ 0\\.055192661162938396\ \(0\)\
\-\ cells\\:\\ 0\\.05515841451199513\ \(0\)\
\-\ biopsies\\:\\ 0\\.054244486250603484\ \(0\)\
\-\ previous\\:\\ 0\\.05409422742869623\ \(0\)\
\-\ these\\:\\ 0\\.05390182757136294\ \(0\)\
\-\ malignancy\\:\\ 0\\.053594165717824466\ \(0\)\
\-\ retraction\\:\\ 0\\.053127283521632165\ \(0\)\
\-\ risk\\:\\ 0\\.05115176329086694\ \(0\)\
\-\ confused\\:\\ 0\\.0504629109687514\ \(0\)\
\-\ biopsy\\:\\ 0\\.05018142789940107\ \(0\)\
\-\ 12\\:\\ 0\\.04893784811631227\ \(0\)\
\-\ first\\:\\ 0\\.04831104799308075\ \(0\)\
\-\ core\\:\\ 0\\.04786797111607351\ \(0\)\
\-\ combined\\:\\ 0\\.047328003618382436\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.047070549694164486\ \(0\)\
\-\ should\\:\\ 0\\.04671190315813327\ \(0\)\
\-\ is\\:\\ 0\\.045745396130457784\ \(0\)\
\-\ mammogram\\:\\ 0\\.045566294030484795\ \(0\)\
\-\ at\\:\\ 0\\.045066868153880606\ \(0\)\
\-\ needle\\:\\ 0\\.044291721288514885\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0441575044944186\ \(0\)\
\-\ highly\\:\\ 0\\.04272096364983554\ \(0\)\
\-\ uterus\\:\\ 0\\.041862098189047216\ \(0\)\
\-\ degree\\:\\ 0\\.04172715022546718\ \(0\)\
\-\ regular\\:\\ 0\\.04120812539792795\ \(0\)\
\-\ due\\:\\ 0\\.04115077361468514\ \(0\)\
\-\ subtle\\:\\ 0\\.041145454001088905\ \(0\)\
\-\ cm\\:\\ 0\\.0411144497440718\ \(0\)\
\-\ than\\:\\ 0\\.040581842724421675\ \(0\)\
\-\ more\\:\\ 0\\.039310089643482836\ \(0\)\
\-\ frequently\\:\\ 0\\.039303515122997276\ \(0\)\
\-\ compared\\:\\ 0\\.038583880463250474\ \(0\)\
\-\ metastases\\:\\ 0\\.038583880463250474\ \(0\)\
\-\ features\\:\\ 0\\.03840199085721388\ \(0\)\
\-\ mmgs\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ brca2\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ chrt\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ permeating\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ overestimating\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ ilcs\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ definable\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ infrequency\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ sparseness\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ gynecological\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ leoptomeningeal\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ performation\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ extragenital\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ parametrium\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ invation\\:\\ 0\\.03816220156731554\ \(0\)\
\-\ position\\:\\ 0\\.03804966122573547\ \(0\)\
\-\ us\\:\\ 0\\.0379638492698256\ \(0\)\
\-\ especially\\:\\ 0\\.037753092726501986\ \(0\)\
\-\ not\\:\\ 0\\.03768224773706947\ \(0\)\
\-\ tissue\\:\\ 0\\.037554044273945035\ \(0\)\
\-\ tumor\\:\\ 0\\.037445268827767754\ \(0\)\
\-\ most\\:\\ 0\\.03725715134462483\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03711129785521591\ \(0\)\
\-\ small\\:\\ 0\\.03692808454972514\ \(0\)\
\-\ measuring\\:\\ 0\\.03692168374658581\ \(0\)\
\-\ mri\\:\\ 0\\.036747507498531576\ \(0\)\
\-\ premarin\\:\\ 0\\.036466020930022096\ \(0\)\
\-\ brca1\\:\\ 0\\.036466020930022096\ \(0\)\
\-\ menopause\\:\\ 0\\.036466020930022096\ \(0\)\
\-\ pathomnemonic\\:\\ 0\\.036466020930022096\ \(0\)\
\-\ files\\:\\ 0\\.036466020930022096\ \(0\)\
\-\ fnas\\:\\ 0\\.036466020930022096\ \(0\)\
\-\ idc\\:\\ 0\\.036466020930022096\ \(0\)\
\-\ mass\\:\\ 0\\.03646018236112305\ \(0\)\
\-\ system\\:\\ 0\\.03641002961722552\ \(0\)\
\-\ similar\\:\\ 0\\.036374652852648154\ \(0\)\
\-\ change\\:\\ 0\\.03616547714869763\ \(0\)\
\-\ exam\\:\\ 0\\.036038004111234624\ \(0\)\
\-\ but\\:\\ 0\\.03540093691054671\ \(0\)\
\-\ findings\\:\\ 0\\.035332107367620616\ \(0\)\
\-\ hardened\\:\\ 0\\.03526256161569068\ \(0\)\
\-\ montly\\:\\ 0\\.03526256161569068\ \(0\)\
\-\ 1ppd\\:\\ 0\\.03526256161569068\ \(0\)\
\-\ inducing\\:\\ 0\\.03526256161569068\ \(0\)\
\-\ linitis\\:\\ 0\\.03526256161569068\ \(0\)\
\-\ plastica\\:\\ 0\\.03526256161569068\ \(0\)\
\-\ metastasis\\:\\ 0\\.03497969540988253\ \(0\)\
\-\ pt\\:\\ 0\\.034346867998275556\ \(0\)\
\-\ hypoechogenicity\\:\\ 0\\.03432908605020481\ \(0\)\
\-\ p53\\:\\ 0\\.03432908605020481\ \(0\)\
\-\ childbirth\\:\\ 0\\.033566380978397224\ \(0\)\
\-\ ureteric\\:\\ 0\\.033566380978397224\ \(0\)\
\-\ obstruction\\:\\ 0\\.033429421674842266\ \(0\)\
\-\ 50\\:\\ 0\\.03333069967567028\ \(0\)\
\-\ weight\\:\\ 0\\.03328177209554718\ \(0\)\
\-\ historically\\:\\ 0\\.032921523028551475\ \(0\)\
\-\ speculated\\:\\ 0\\.032921523028551475\ \(0\)\
\-\ has\\:\\ 0\\.03269982888962587\ \(0\)\
\-\ which\\:\\ 0\\.0325522899261953\ \(0\)\
\-\ gained\\:\\ 0\\.03236292166406582\ \(0\)\
\-\ undetected\\:\\ 0\\.03236292166406582\ \(0\)\
\-\ acr\\:\\ 0\\.03236292166406582\ \(0\)\
\-\ cases\\:\\ 0\\.03210078309301358\ \(0\)\
\-\ fhx\\:\\ 0\\.03187020034110377\ \(0\)\
\-\ gynecologic\\:\\ 0\\.03187020034110377\ \(0\)\
\-\ leptomeninges\\:\\ 0\\.03187020034110377\ \(0\)\
\-\ density\\:\\ 0\\.031647309964579665\ \(0\)\
\-\ lmp\\:\\ 0\\.03142944609857994\ \(0\)\
\-\ indian\\:\\ 0\\.03142944609857994\ \(0\)\
\-\ reporting\\:\\ 0\\.03142944609857994\ \(0\)\
\-\ finding\\:\\ 0\\.03137102945360083\ \(0\)\
\-\ asymmetrical\\:\\ 0\\.03103073538762543\ \(0\)\
\-\ progesterone\\:\\ 0\\.03103073538762543\ \(0\)\
\-\ tethering\\:\\ 0\\.03103073538762543\ \(0\)\
\-\ aspect\\:\\ 0\\.030789912713386606\ \(0\)\
\-\ glandular\\:\\ 0\\.03066674102677236\ \(0\)\
\-\ yield\\:\\ 0\\.03066674102677236\ \(0\)\
\-\ bowel\\:\\ 0\\.030628494349168464\ \(0\)\
\-\ approximately\\:\\ 0\\.030452719137069442\ \(0\)\
\-\ circular\\:\\ 0\\.030331898673639043\ \(0\)\
\-\ relevant\\:\\ 0\\.030331898673639043\ \(0\)\
\-\ file\\:\\ 0\\.030331898673639043\ \(0\)\
\-\ inconclusive\\:\\ 0\\.030331898673639043\ \(0\)\
\-\ clinical\\:\\ 0\\.030246550371925224\ \(0\)\
\-\ feed\\:\\ 0\\.030021883076926607\ \(0\)\
\-\ adjunct\\:\\ 0\\.030021883076926607\ \(0\)\
\-\ vagina\\:\\ 0\\.030021883076926607\ \(0\)\
\-\ estrogen\\:\\ 0\\.029733265461286483\ \(0\)\
\-\ mammographic\\:\\ 0\\.029733265461286483\ \(0\)\
\-\ college\\:\\ 0\\.029733265461286483\ \(0\)\
\-\ knowledge\\:\\ 0\\.029733265461286483\ \(0\)\
\-\ manifests\\:\\ 0\\.029733265461286483\ \(0\)\
\-\ retroperitoneum\\:\\ 0\\.029733265461286483\ \(0\)\
\-\ wks\\:\\ 0\\.02946328171244095\ \(0\)\
\-\ genetics\\:\\ 0\\.02946328171244095\ \(0\)\
\-\ interpretation\\:\\ 0\\.02946328171244095\ \(0\)\
\-\ primary\\:\\ 0\\.02934639482902628\ \(0\)\
\-\ demonstrated\\:\\ 0\\.02933116899705869\ \(0\)\
\-\ years\\:\\ 0\\.029255452712364325\ \(0\)\
\-\ hodgkins\\:\\ 0\\.029209670963668843\ \(0\)\
\-\ arranged\\:\\ 0\\.029209670963668843\ \(0\)\
\-\ metastasize\\:\\ 0\\.029209670963668843\ \(0\)\
\-\ mammary\\:\\ 0\\.028744381189352918\ \(0\)\
\-\ correlated\\:\\ 0\\.028744381189352918\ \(0\)\
\-\ insidious\\:\\ 0\\.028529806146955074\ \(0\)\
\-\ action\\:\\ 0\\.028529806146955074\ \(0\)\
\-\ there\\:\\ 0\\.028485092859492064\ \(0\)\
\-\ include\\:\\ 0\\.028396587251576\ \(0\)\
\-\ accounting\\:\\ 0\\.028325702439633154\ \(0\)\
\-\ categories\\:\\ 0\\.028325702439633154\ \(0\)\
\-\ peritoneum\\:\\ 0\\.028131095436000564\ \(0\)\
\-\ exhibits\\:\\ 0\\.027945140547507175\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.027945140547507175\ \(0\)\
\-\ fna\\:\\ 0\\.027945140547507175\ \(0\)\
\-\ genitourinary\\:\\ 0\\.027945140547507175\ \(0\)\
\-\ 10\\:\\ 0\\.02790779173210358\ \(0\)\
\-\ been\\:\\ 0\\.027805758853443538\ \(0\)\
\-\ architectural\\:\\ 0\\.027767101075147495\ \(0\)\
\-\ confluent\\:\\ 0\\.027596330581469198\ \(0\)\
\-\ therapy\\:\\ 0\\.027421732358398166\ \(0\)\
\-\ history\\:\\ 0\\.027351192205717658\ \(0\)\
\-\ lymphatic\\:\\ 0\\.027274379752185454\ \(0\)\
\-\ score\\:\\ 0\\.027122243125301742\ \(0\)\
\-\ planning\\:\\ 0\\.027122243125301742\ \(0\)\
\-\ revealing\\:\\ 0\\.027122243125301742\ \(0\)\
\-\ common\\:\\ 0\\.02706615792674057\ \(0\)\
\-\ graded\\:\\ 0\\.026975445741234182\ \(0\)\
\-\ twice\\:\\ 0\\.02683362550966162\ \(0\)\
\-\ individual\\:\\ 0\\.02683362550966162\ \(0\)\
\-\ prior\\:\\ 0\\.026702829529737532\ \(0\)\
\-\ pcp\\:\\ 0\\.026696455969150126\ \(0\)\
\-\ mammograms\\:\\ 0\\.026696455969150126\ \(0\)\
\-\ diagnose\\:\\ 0\\.026696455969150126\ \(0\)\
\-\ carcinomas\\:\\ 0\\.026696455969150126\ \(0\)\
\-\ mlo\\:\\ 0\\.026563641760816083\ \(0\)\
\-\ advised\\:\\ 0\\.026563641760816083\ \(0\)\
\-\ unlike\\:\\ 0\\.026563641760816083\ \(0\)\
\-\ nodularity\\:\\ 0\\.026434914798707108\ \(0\)\
\-\ obesity\\:\\ 0\\.026434914798707108\ \(0\)\
\-\ histological\\:\\ 0\\.026310031012043978\ \(0\)\
\-\ tx\\:\\ 0\\.026188767559815865\ \(0\)\
\-\ produces\\:\\ 0\\.026188767559815865\ \(0\)\
\-\ metastatic\\:\\ 0\\.02617537126790353\ \(0\)\
\-\ breasts\\:\\ 0\\.026070920437854042\ \(0\)\
\-\ attention\\:\\ 0\\.026070920437854042\ \(0\)\
\-\ bone\\:\\ 0\\.026040840601131827\ \(0\)\
\-\ prompt\\:\\ 0\\.02595630241383609\ \(0\)\
\-\ constipation\\:\\ 0\\.02595630241383609\ \(0\)\
\-\ diet\\:\\ 0\\.02595630241383609\ \(0\)\
\-\ preoperative\\:\\ 0\\.02595630241383609\ \(0\)\
\-\ ureters\\:\\ 0\\.02595630241383609\ \(0\)\
\-\ physical\\:\\ 0\\.02587817997632518\ \(0\)\
\-\ distortion\\:\\ 0\\.0252314554843757\ \(0\)\
\-\ nipple\\:\\ 0\\.0252314554843757\ \(0\)\
\-\ without\\:\\ 0\\.025173716534830623\ \(0\)\
\-\ classically\\:\\ 0\\.024955533769765847\ \(0\)\
\-\ younger\\:\\ 0\\.024955533769765847\ \(0\)\
\-\ was\\:\\ 0\\.024949520752143465\ \(0\)\
\-\ connective\\:\\ 0\\.024781204538162533\ \(0\)\
\-\ planes\\:\\ 0\\.024613850374750522\ \(0\)\
\-\ ducts\\:\\ 0\\.024613850374750522\ \(0\)\
\-\ this\\:\\ 0\\.02459931446162594\ \(0\)\
\-\ self\\:\\ 0\\.02453261877038931\ \(0\)\
\-\ mets\\:\\ 0\\.02453261877038931\ \(0\)\
\-\ smoker\\:\\ 0\\.024452934529159698\ \(0\)\
\-\ manifestations\\:\\ 0\\.024452934529159698\ \(0\)\
\-\ intermediate\\:\\ 0\\.02437473980056059\ \(0\)\
\-\ value\\:\\ 0\\.024297979918889823\ \(0\)\
\-\ exams\\:\\ 0\\.024222603173676874\ \(0\)\
\-\ acoustic\\:\\ 0\\.023933985558036754\ \(0\)\
\-\ greatest\\:\\ 0\\.02386483859234978\ \(0\)\
\-\ contralateral\\:\\ 0\\.02386483859234978\ \(0\)\
\-\ right\\:\\ 0\\.023734758827848052\ \(0\)\
\-\ noticed\\:\\ 0\\.023664001809191218\ \(0\)\
\-\ information\\:\\ 0\\.023599143204903434\ \(0\)\
\-\ definite\\:\\ 0\\.023472366952169314\ \(0\)\
\-\ little\\:\\ 0\\.023472366952169314\ \(0\)\
\-\ final\\:\\ 0\\.02341039106041911\ \(0\)\
\-\ data\\:\\ 0\\.02341039106041911\ \(0\)\
\-\ follows\\:\\ 0\\.023349319958588854\ \(0\)\
\-\ vague\\:\\ 0\\.023349319958588854\ \(0\)\
\-\ assessment\\:\\ 0\\.023349319958588854\ \(0\)\
\-\ ovary\\:\\ 0\\.023349319958588854\ \(0\)\
\-\ multifocal\\:\\ 0\\.023171280486229177\ \(0\)\
\-\ probably\\:\\ 0\\.023171280486229177\ \(0\)\
\-\ after\\:\\ 0\\.0231527071804607\ \(0\)\
\-\ cc\\:\\ 0\\.023113578934463152\ \(0\)\
\-\ taking\\:\\ 0\\.023113578934463152\ \(0\)\
\-\ zone\\:\\ 0\\.023056662462211223\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.023000509992550877\ \(0\)\
\-\ tests\\:\\ 0\\.02283643813309586\ \(0\)\
\-\ generalized\\:\\ 0\\.022783147015242398\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.02273052624370534\ \(0\)\
\-\ longitudinal\\:\\ 0\\.022678559163267133\ \(0\)\
\-\ shape\\:\\ 0\\.022627229731817064\ \(0\)\
\-\ diarrhea\\:\\ 0\\.022576522490623002\ \(0\)\
\-\ better\\:\\ 0\\.02252642253638342\ \(0\)\
\-\ exercise\\:\\ 0\\.022476915494933233\ \(0\)\
\-\ also\\:\\ 0\\.022448983534803516\ \(0\)\
\-\ peritoneal\\:\\ 0\\.02242798749648744\ \(0\)\
\-\ suggested\\:\\ 0\\.02233181553275083\ \(0\)\
\-\ obvious\\:\\ 0\\.0221915801832501\ \(0\)\
\-\ combination\\:\\ 0\\.022145860644257442\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.022145860644257442\ \(0\)\
\-\ pet\\:\\ 0\\.022100635380231805\ \(0\)\
\-\ annual\\:\\ 0\\.022055893818140982\ \(0\)\
\-\ alcohol\\:\\ 0\\.022055893818140982\ \(0\)\
\-\ adult\\:\\ 0\\.02201162572061731\ \(0\)\
\-\ need\\:\\ 0\\.021967821171897765\ \(0\)\
\-\ frequent\\:\\ 0\\.021881564586537665\ \(0\)\
\-\ conditions\\:\\ 0\\.021797050678219465\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.021755425497185874\ \(0\)\
\-\ somewhat\\:\\ 0\\.021714210423125657\ \(0\)\
\-\ majority\\:\\ 0\\.021673397453759225\ \(0\)\
\-\ on\\:\\ 0\\.02162114622504264\ \(0\)\
\-\ interval\\:\\ 0\\.021592946970897545\ \(0\)\
\-\ asymmetric\\:\\ 0\\.02147509984893572\ \(0\)\
\-\ replacement\\:\\ 0\\.02143654385085607\ \(0\)\
\-\ discharge\\:\\ 0\\.021398339967264954\ \(0\)\
\-\ invasion\\:\\ 0\\.02128577812228991\ \(0\)\
\-\ observed\\:\\ 0\\.021248920648809733\ \(0\)\
\-\ become\\:\\ 0\\.02117616583798445\ \(0\)\
\-\ markedly\\:\\ 0\\.0210693524732799\ \(0\)\
\-\ dense\\:\\ 0\\.021034345606411885\ \(0\)\
\-\ direct\\:\\ 0\\.021034345606411885\ \(0\)\
\-\ 33\\:\\ 0\\.020999629256310444\ \(0\)\
\-\ prognosis\\:\\ 0\\.020999629256310444\ \(0\)\
\-\ appropriate\\:\\ 0\\.020965198640724915\ \(0\)\
\-\ orbital\\:\\ 0\\.020931049094523608\ \(0\)\
\-\ 29\\:\\ 0\\.020797172191866928\ \(0\)\
\-\ scans\\:\\ 0\\.020764361857566353\ \(0\)\
\-\ much\\:\\ 0\\.020667447187005143\ \(0\)\
\-\ showing\\:\\ 0\\.020604062698963976\ \(0\)\
\-\ kidneys\\:\\ 0\\.020541624283449845\ \(0\)\
\-\ 55\\:\\ 0\\.020510751108794245\ \(0\)\
\-\ short\\:\\ 0\\.020510751108794245\ \(0\)\
\-\ lack\\:\\ 0\\.02041947557120815\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.020389487656566133\ \(0\)\
\-\ ca\\:\\ 0\\.02035971318084753\ \(0\)\
\-\ margins\\:\\ 0\\.02035971318084753\ \(0\)\
\-\ american\\:\\ 0\\.02035971318084753\ \(0\)\
\-\ ovarian\\:\\ 0\\.020330149127209835\ \(0\)\
\-\ reaction\\:\\ 0\\.02030079254232406\ \(0\)\
\-\ factors\\:\\ 0\\.020185383949244212\ \(0\)\
\-\ disease\\:\\ 0\\.0200337158461153\ \(0\)\
\-\ apparent\\:\\ 0\\.019963700500414516\ \(0\)\
\-\ stomach\\:\\ 0\\.019910067763502553\ \(0\)\
\-\ until\\:\\ 0\\.019857113940241377\ \(0\)\
\-\ clinically\\:\\ 0\\.019830886292080473\ \(0\)\
\-\ marrow\\:\\ 0\\.019830886292080473\ \(0\)\
\-\ difficult\\:\\ 0\\.01980482205711823\ \(0\)\
\-\ do\\:\\ 0\\.01977891921164227\ \(0\)\
\-\ growth\\:\\ 0\\.019676882538998137\ \(0\)\
\-\ esophagus\\:\\ 0\\.019651757561498638\ \(0\)\
\-\ atypical\\:\\ 0\\.01957727554330837\ \(0\)\
\-\ pathologic\\:\\ 0\\.019552740011516277\ \(0\)\
\-\ pregnancy\\:\\ 0\\.019528347544862573\ \(0\)\
\-\ normal\\:\\ 0\\.019486241311260963\ \(0\)\
\-\ suggestive\\:\\ 0\\.019432175581125966\ \(0\)\
\-\ last\\:\\ 0\\.01940847412294417\ \(0\)\
\-\ test\\:\\ 0\\.01940847412294417\ \(0\)\
\-\ screening\\:\\ 0\\.019384906194812614\ \(0\)\
\-\ parenchyma\\:\\ 0\\.019384906194812614\ \(0\)\
\-\ before\\:\\ 0\\.019291940231625237\ \(0\)\
\-\ site\\:\\ 0\\.019246220692632574\ \(0\)\
\-\ previously\\:\\ 0\\.019156253866516117\ \(0\)\
\-\ radiology\\:\\ 0\\.019111985768992444\ \(0\)\
\-\ taken\\:\\ 0\\.019068181220272897\ \(0\)\
\-\ around\\:\\ 0\\.01904644976268252\ \(0\)\
\-\ limited\\:\\ 0\\.01904644976268252\ \(0\)\
\-\ stage\\:\\ 0\\.019003322615985113\ \(0\)\
\-\ nodules\\:\\ 0\\.018960635549889707\ \(0\)\
\-\ views\\:\\ 0\\.018835127250845244\ \(0\)\
\-\ ii\\:\\ 0\\.01881457047150079\ \(0\)\
\-\ tissues\\:\\ 0\\.01881457047150079\ \(0\)\
\-\ many\\:\\ 0\\.01881457047150079\ \(0\)\
\-\ family\\:\\ 0\\.018773757502134357\ \(0\)\
\-\ pathology\\:\\ 0\\.018733338867139578\ \(0\)\
\-\ delayed\\:\\ 0\\.01867343384090672\ \(0\)\
\-\ full\\:\\ 0\\.01865365462590997\ \(0\)\
\-\ considered\\:\\ 0\\.018594871979376697\ \(0\)\
\-\ shown\\:\\ 0\\.01849870001564009\ \(0\)\
\-\ additional\\:\\ 0\\.01849870001564009\ \(0\)\
\-\ transverse\\:\\ 0\\.018386138170665044\ \(0\)\
\-\ single\\:\\ 0\\.018349280697184868\ \(0\)\
\-\ nausea\\:\\ 0\\.018330973026045524\ \(0\)\
\-\ attenuation\\:\\ 0\\.018258533186886135\ \(0\)\
\-\ an\\:\\ 0\\.01825029547040227\ \(0\)\
\-\ unknown\\:\\ 0\\.018082738574348816\ \(0\)\
\-\ second\\:\\ 0\\.01786472190594149\ \(0\)\
\-\ pattern\\:\\ 0\\.01781598392344715\ \(0\)\
\-\ active\\:\\ 0\\.01772017906042409\ \(0\)\
\-\ radiographic\\:\\ 0\\.017704422747339108\ \(0\)\
\-\ vomiting\\:\\ 0\\.017657506784434798\ \(0\)\
\-\ throughout\\:\\ 0\\.01755004005533912\ \(0\)\
\-\ tumors\\:\\ 0\\.01755004005533912\ \(0\)\
\-\ studies\\:\\ 0\\.017504814791313484\ \(0\)\
\-\ view\\:\\ 0\\.01747493397727897\ \(0\)\
\-\ ago\\:\\ 0\\.017460073229222665\ \(0\)\
\-\ abnormality\\:\\ 0\\.01735750040839727\ \(0\)\
\-\ involvement\\:\\ 0\\.017271539243126882\ \(0\)\
\-\ early\\:\\ 0\\.017201230089301144\ \(0\)\
\-\ mid\\:\\ 0\\.017173433999137778\ \(0\)\
\-\ did\\:\\ 0\\.017118389834207336\ \(0\)\
\-\ venous\\:\\ 0\\.01703715822984613\ \(0\)\
\-\ malignant\\:\\ 0\\.017010427811877685\ \(0\)\
\-\ identified\\:\\ 0\\.016918193923693238\ \(0\)\
\-\ palpable\\:\\ 0\\.016764661235999453\ \(0\)\
\-\ involving\\:\\ 0\\.016714710837421133\ \(0\)\
\-\ signs\\:\\ 0\\.0166776355916835\ \(0\)\
\-\ because\\:\\ 0\\.0166776355916835\ \(0\)\
\-\ being\\:\\ 0\\.01662870759323771\ \(0\)\
\-\ does\\:\\ 0\\.01649703361009909\ \(0\)\
\-\ side\\:\\ 0\\.01648526624318775\ \(0\)\
\-\ neoplasm\\:\\ 0\\.016290125144925824\ \(0\)\
\-\ 30\\:\\ 0\\.016278924880728993\ \(0\)\
\-\ less\\:\\ 0\\.016234421310171648\ \(0\)\
\-\ areas\\:\\ 0\\.01620135160294861\ \(0\)\
\-\ size\\:\\ 0\\.01615766142850088\ \(0\)\
\-\ recent\\:\\ 0\\.01615766142850088\ \(0\)\
\-\ inflammatory\\:\\ 0\\.016135986270275668\ \(0\)\
\-\ type\\:\\ 0\\.01600824211004566\ \(0\)\
\-\ unremarkable\\:\\ 0\\.015997770774969732\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.01597690641162613\ \(0\)\
\-\ radiation\\:\\ 0\\.01581363510641307\ \(0\)\
\-\ several\\:\\ 0\\.01565649752713632\ \(0\)\
\-\ revealed\\:\\ 0\\.015646869683580252\ \(0\)\
\-\ mr\\:\\ 0\\.015440476894844953\ \(0\)\
\-\ any\\:\\ 0\\.015422209196913884\ \(0\)\
\-\ examination\\:\\ 0\\.01527007257003017\ \(0\)\
\-\ her\\:\\ 0\\.01490827589568868\ \(0\)\
\-\ negative\\:\\ 0\\.014773447097294718\ \(0\)\
\-\ evaluation\\:\\ 0\\.014553022653554301\ \(0\)\
\-\ wall\\:\\ 0\\.014516165180074123\ \(0\)\
\-\ changes\\:\\ 0\\.014421828397844715\ \(0\)\
\-\ when\\:\\ 0\\.014414659079588556\ \(0\)\
\-\ appearance\\:\\ 0\\.014386104045994481\ \(0\)\
\-\ following\\:\\ 0\\.014315557750580939\ \(0\)\
\-\ however\\:\\ 0\\.014124131719026625\ \(0\)\
\-\ presented\\:\\ 0\\.013915575327752044\ \(0\)\
\-\ if\\:\\ 0\\.013865021284374586\ \(0\)\
\-\ one\\:\\ 0\\.013662712597967816\ \(0\)\
\-\ mild\\:\\ 0\\.013527280908140558\ \(0\)\
\-\ both\\:\\ 0\\.013307205146766612\ \(0\)\
\-\ increased\\:\\ 0\\.01290399922128999\ \(0\)\
\-\ bilateral\\:\\ 0\\.012824880150335973\ \(0\)\
\-\ can\\:\\ 0\\.012522569245289017\ \(0\)\
\-\ other\\:\\ 0\\.01239246161179929\ \(0\)\
\-\ present\\:\\ 0\\.01224490267301943\ \(0\)\
\-\ large\\:\\ 0\\.011956569354921202\ \(0\)\
\-\ had\\:\\ 0\\.011889445654269429\ \(0\)\
\-\ well\\:\\ 0\\.011554603301136113\ \(0\)\
\-\ lesion\\:\\ 0\\.0114404739057357\ \(0\)\
\-\ seen\\:\\ 0\\.011234527668685127\ \(0\)\
\-\ within\\:\\ 0\\.010990581988349327\ \(0\)\
\-\ that\\:\\ 0\\.010355665980736074\ \(0\)\
\-\ ct\\:\\ 0\\.009084884708522945\ \(0\)\
\-\ pain\\:\\ 0\\.00853907515813009\ \(0\)\
\-\ left\\:\\ 0\\.008140204593293043\ \(0\)\
\-\ patient\\:\\ 0\\.007761450100920042\ \(0\)\
\-\ year\\:\\ 0\\.007354120185660875\ \(0\)\
